BioMarin Pharmaceutical Inc. (BMRN)

BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	11,594	12,527	18,162	19,234	16,220	15,918
Market Cap Growth	-6.41%	-31.03%	-5.57%	18.57%	1.90%	4.81%
Enterprise Value	10,721	12,199	18,132	19,051	16,229	15,917
Last Close Price	60.35	65.73	96.42	103.49	88.35	87.69
PE Ratio	22.51	29.35	108.34	135.87	-	18.64
Forward PE	13.66	17.86	38.98	39.00	85.79	75.56
PS Ratio	3.73	4.39	7.51	9.18	8.79	8.56
PB Ratio	1.91	2.21	3.67	4.18	3.80	3.88
P/TBV Ratio	2.06	2.44	4.10	4.73	4.41	4.56
P/FCF Ratio	13.93	25.70	290.28	350.06	77.63	-
P/OCF Ratio	12.69	21.87	114.04	109.34	53.26	186.47
PEG Ratio	0.72	0.72	1.07	0.86	2.66	1.75
EV/Sales Ratio	3.46	4.28	7.50	9.09	8.79	8.56
EV/EBITDA Ratio	13.50	18.30	62.49	121.62	481.22	1186.81
EV/EBIT Ratio	15.07	21.40	97.60	348.42	-	-
EV/FCF Ratio	12.88	25.03	289.80	346.74	77.67	-
Debt / Equity Ratio	0.10	0.11	0.23	0.24	0.26	0.28
Debt / EBITDA Ratio	0.75	0.93	3.73	6.58	23.56	43.10
Debt / FCF Ratio	0.73	1.30	18.12	20.38	5.38	-
Asset Turnover	0.43	0.41	0.37	0.34	0.31	0.35
Inventory Turnover	0.45	0.50	0.53	0.60	1.49	1.67
Quick Ratio	2.84	2.96	1.45	2.98	2.54	3.07
Current Ratio	4.83	5.33	2.51	4.67	4.16	4.76
Return on Equity (ROE)	9.07%	8.05%	3.51%	3.19%	-1.53%	23.63%
Return on Assets (ROA)	6.15%	5.15%	1.76%	0.55%	-0.78%	-1.09%
Return on Capital (ROIC)	7.01%	5.76%	1.97%	0.61%	-0.87%	-1.24%
Return on Capital Employed (ROCE)	10.40%	8.90%	3.30%	0.90%	-1.40%	-1.70%
Earnings Yield	4.49%	3.41%	0.92%	0.74%	-0.40%	5.37%
FCF Yield	7.18%	3.89%	0.34%	0.29%	1.29%	-0.18%
Buyback Yield / Dilution	-2.10%	-2.67%	-1.39%	-3.34%	4.61%	-7.06%

Updated Oct 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q